Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain

Clinical Infectious Diseases

Volumn 56, Issue 1, 2013, Pages 143-150

  Merchante, Nicolás ^a   Merino, Esperanza ^c   López Aldeguer, José ^g   Jover, Francisco ^d   Delgado Fernández, Marcial ^j   Galindo, Maria José ^h   Ortega, Enrique ⁱ   Rivero, Antonio ^l,m   Mínguez, Carlos ⁿ   Romero Palacios, Alberto ^o   Padilla, Sergio ^e   Márquez Solero, Manuel ^k   Amador, Concepción ^f   Ríos Villegas, Maria José ^b   Téllez, Francisco ^p   Portilla, Joaquín ^c   Pineda, Juan A ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^d HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^f HOSPITAL MARINA BAIXA   (Spain)

^g HOSPITAL UNIVERSITARIO LA FE   (Spain)

^h Hospital Clinico de Valencia   (Spain)

ⁱ Hospital General de Valencia   (Spain)

^j Hospital Regional Carlos Haya   (Spain)

^k HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^l HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^m Instituto de Salud Carlos III   (Spain)

ⁿ HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^o HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

^p Hospital de la Linea de la Concepcion   (Spain)

more..

Author keywords

cirrhosis; hepatitis C virus; hepatocellular carcinoma; HIV; liver transplantation

Indexed keywords

ALCOHOL; SORAFENIB;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SPAIN; SURVIVAL RATE; SURVIVAL TIME;

CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SPAIN; SURVIVAL ANALYSIS;

EID: 84871215063     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis777     Document Type: Article

References (34)

1. Antiretroviral therapy cohort collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010; 50:1387-96.
2. Weber R, Sabin C, Friis-Moller N, et al. Liver-related deaths in persons infected with the HIV: the D:A:D study. Arch Intern Med 2006; 166:1632-41.
3. Pineda JA, García-García JA, Aguilar-Guisado M, et al. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology 2007; 46:622-30.
4. Pineda JA, Romero-Gómez M, Díaz-García F, et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 2005; 41:779-89.
5. Girón-González JA, Brun F, Terrón A, Vergara A, Arizcorreta A. Natural history of compensated and decompensated HCV-related cirrosis in HIV-infected patients: a prospective multicentre study. Antivir Ther 2007; 12:899-907.
6. Merchante N, Girón-González JA, González-Serrano M, et al. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS 2006; 20:49-57.
7. Garcia-Samaniego J, Rodriguez M, Berenguer J, et al. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C. Am J Gastroenterol 2001; 96:179-83.
8. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El Serag HB. Hepatitis C infection and the increased incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004; 127:1372-80.
9. Puoti M, Bruno R, Soriano V, et al. Hepatocellular carcinoma in HIVinfected patients: epidemiological features, clinical presentation and outcome. AIDS 2004; 18:2285-93.
10. Kramer JR, Giordano TP, Souchek J, Richardson P, Hwang LY, El Serag HB. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. Veterans with hepatitis C. Am J Gastroenterol 2005; 100:56-63.
11. García-García JA, Romero-Gómez M, Girón-González JA, et al. Incidence of and factors associated with hepatocellular carcinoma among hepatitis C virus and human immunodeficiency virus coinfected patients with decompensated cirrhosis. AIDS Res Hum Retroviruses 2006; 22:1236-41.
12. Bruno R, Sacchi P, Puoti M, et al. Natural history of compensated viral cirrhosis in a cohort of patients with HIV infection. J Acquir Immune Defic Syndr 2007; 46:297-303.
13. Sulkowski M. Hepatocellular carcinoma in HIV-infected patients comes of age: The convergence of epidemiology and treatment effectiveness. J Hepatol 2009; 50:655-8.
14. Merchante N, Jiménez-Saenz M, Pineda JA. Management of HCVrelated end stage liver disease in HIV-coinfected patients. AIDS Rev 2007; 9:131-9.
15. Macdonald DC, Nelson M, Bower M, Powles T. Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. World J Gastroenterol 2008; 14:1657-63.
16. Castells L, Vargas V, González A, Esteban J, Esteban R, Guardia J. Long interval between HCV infection and development of hepatocellular carcinoma. Liver 1995; 15:159-63.
17. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362:1907-17.
18. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011; 365:1118-27.
19. Bruno R, Puoti M, Sacchi P, Filice C, Carosi G, Filice G. Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients. J Hepatol 2006; 44(Suppl 1):146-50.
20. Salmon-Ceron D, Rosenthal E, Lewden C, et al. Emerging role of hepatocellular among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study. J Hepatol 2009; 50:736-45.
21. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42:1208-36.
22. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 1996; 334:693-9.
23. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329-38.
24. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53:1020-2.
25. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*-Stat database: incidence-SEER 9 Regs research data, Nov 2009 Sub (1973-2007). Bethseda, MD: National Cancer Institute, 2010.
26. Neukam K, Macías J, Mira JA, Pineda JA. A review of current anti-HCV treatment regimens and possible future strategies. Expert Opin Pharmacother 2009; 10:417-33.
27. Altavilla G, Caputo A, Lanfredi M, Piola C, Barbanti-Brodano G, Corallini A. Enhacement of chemical hepatocarcinogenesis by the HIV-1 tat gene. Am J Pathol 2000; 157:1081-9.
28. Brau N, Fox RK, Xiao P, et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol 2007; 47:527-37.
29. Garlassi E, Ventura P, Cacopardo B, et al. Hepatocellular carcinoma in HIV infected patients: check early, treat hard. Oncologist 2011; 16:1258-69.
30. Joshi D, O'Grady J, Dieterich D, et al. Increasing burden of liver disease in patients with HIV infection. Lancet 2011; 377:1198-209.
31. Puoti M, Rossotti R, Garlaschelli A, Bruno R. Hepatocellular carcinoma in HIV hepatitis C virus. Curr Opin HIV AIDS 2011; 6:534-8.
32. Pineda JA, Aguilar-Guisado M, Rivero A, et al. Natural history of compensated liver hepatitis C virus-related cirrhosis in HIV-infected patients. Clin Infect Dis 2009; 49:1274-82.
33. Bruno S, Stroffolini T, Colombo M, et al. Sustained virological response to interferon-alpha is associated with improved outcome in HCVrelated cirrhosis: a retrospective study. Hepatology 2007; 45:579-87.
34. Berenguer J, Alvarez-Pellicer J, Martín PM, et al. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2009; 50:407-13.